ReviewDrugs2022

First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?

Jacob J Adashek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.